RBC Capital Reiterates Outperform on Boston Scientific, Maintains $67 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh has reiterated an Outperform rating on Boston Scientific (NYSE:BSX) and maintained a price target of $67.
January 16, 2024 | 2:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital analyst reaffirms Outperform rating on Boston Scientific with a $67 price target, indicating a positive outlook for the stock.
The reiteration of an Outperform rating by a major analyst like RBC Capital suggests a positive sentiment towards Boston Scientific's stock. The maintained price target of $67 implies that the analyst believes the stock has the potential to reach or exceed this target in the short term, which could influence investor confidence and potentially drive the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100